Todays Report: Theravance Biopharma Inc (TBPHV) gets Underperform status at Robert W. Baird

Theravance Biopharma Inc (TBPHV) gets Underperform status at Robert W. Baird

Robert W. Baird downgraded shares of Theravance Biopharma Inc (NASDAQ:TBPHV) from a neutral rating to an underperform rating in a research report released on Wednesday morning. Robert W. Baird currently has $24.00 price objective on the stock, up from their previous price objective of $19.00.

About Theravance Biopharma

Related posts

Leave a Comment